Optas LLC’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
774
-386
-33% -$163K 0.04% 314
2026
Q1
$549K Buy
1,160
+156
+16% +$78.5K 0.08% 151
2025
Q4
$469K Buy
1,004
+244
+32% +$113K 0.07% 185
2025
Q3
$324K Buy
760
+33
+5% +$12.8K 0.06% 233
2025
Q2
$279K Buy
727
+85
+13% +$30.6K 0.05% 234
2025
Q1
$222K Buy
+642
New +$206K 0.04% 260
2024
Q4
Sell
-785
Closed -$319K 286
2024
Q3
$319K Buy
785
+147
+23% +$53.8K 0.07% 160
2024
Q2
$205K Buy
+638
New +$207K 0.05% 193

Other funds holding HCA

Optas LLC's HCA Position: Q2 2026 in Review

Optas LLC reduced its HCA Healthcare (HCA) stake by 33% in Q2 2026, selling an estimated $163K and leaving 774 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #314.

Optas LLC first reported a position in HCA in Q2 2024 and has held it in 8 quarters since. The position peaked at $549K in Q1 2026. 307 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Optas LLC held 774 shares of HCA Healthcare worth $302K as of Q2 2026.
  • Optas LLC sold 386 HCA Healthcare shares in Q2 2026, an estimated $163K.
  • HCA Healthcare made up 0.04% of Optas LLC's portfolio in Q2 2026, its #314 holding.
  • Optas LLC first reported a position in HCA Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Optas LLC's HCA Healthcare position peaked at $549K in Q1 2026.
  • 307 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.